Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia.
$2.24-1.32%
报价 2026-11-06
市值
$26.8M
EV
$-23.3M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -84.4%
$2.24$14.36
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| IXHLIncannex Healthcare Limited | $26.8M | -1.3% | – | -192.7% | – | – | – | |
| INCRInterCure Ltd. | $41.1M | +5.3% | – | 0.3% | – | – | 14.1x | |
| RMTIRockwell Medical, Inc. | $31.2M | +1.7% | +4.3% | 17.7% | – | – | 21.2x | |
| COSMCosmos Health Inc. | $30.7M | +5.2% | +60.2% | 10.3% | – | – | – | |
| SHPHShuttle Pharmaceuticals Holdings, Inc. | $26.6M | +10.8% | – | 0% | – | – | – | |
| CPHIChina Pharma Holdings, Inc. | $24.5M | +7.5% | – | -9.3% | – | – | – | |
| SCYXSCYNEXIS, Inc. | $22M | +6.1% | -87.9% | 100% | – | – | – | |
| TXMDTherapeuticsMD, Inc. | $20.1M | +1.8% | +1.1% | 89.9% | – | – | 8.5x | |
| AYTUAytu BioPharma, Inc. | $19.9M | +1.1% | +30.7% | 66% | – | – | – | |
| 同行中位数 | – | – | +4.3% | 14% | – | – | 14.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。